Latest Administration News

Multistack International Limited reported a net operating cash outflow of A$180,348 for the September quarter but maintains robust cash reserves of A$1.33 million. The company is planning a strategic disposal of its shares in Multistack Australia, signaling a potential shift in its operational focus.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

Pinnacle Minerals Ltd is fast-tracking its U.S. growth by initiating a listing on the OTCQB Market and appointing key U.S. advisers to boost investor engagement and capital access.

Fiducian Group Limited has voluntarily released its Appendix 4C for Q3 2025, reporting steady net inflows to its core platform and a rise in total funds under management to $15.6 billion.

BlackRock Investment Management (Australia) Limited has updated its estimated cash distributions for the iShares Balanced ESG ETF and the iShares High Growth ESG ETF, providing investors with important timetable details and tax compliance reminders.

Alcidion Group Limited has reported a record FY25 with strong revenue growth, major NHS contract wins, and expanded AI capabilities in its Miya Precision platform, setting the stage for global healthcare IT expansion.

PainChek Limited has confirmed FDA De Novo classification for its PainChek Adult App, promptly disclosing the material regulatory milestone to the ASX and signalling a significant step towards US market entry.

Strike Energy Limited has addressed ASX concerns over a delayed filing of a director’s interest notice, attributing the lapse to administrative oversight while affirming confidence in its compliance processes.

American West Metals has raised A$7 million at a premium to advance its West Desert Project, home to the largest and highest-grade indium resource in the US. The funding includes a strategic $2 million investment from Tribeca Investment Partners and aims to accelerate critical metals development amid supportive US policies.

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.

Clarity Pharmaceuticals has inked a pivotal supply agreement with Nusano to ensure a steady source of copper-67, a critical isotope for its upcoming Phase III prostate cancer trial and future commercialisation plans.

Native Mineral Resources Holdings Limited reported a challenging quarter with negative operating cash flow but secured significant financing to support ongoing exploration activities. The company anticipates improved cash flow performance in coming months.